Holen Sie sich die Stockscreener-App
4.91
1.80%
-0.09
Handel nachbörslich:
4.91
Schlusskurs vom Vortag:
$5.00
Offen:
$4.99
24-Stunden-Volumen:
264.29K
Relative Volume:
0.63
Marktkapitalisierung:
$303.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-130.41M
KGV:
-2.192
EPS:
-2.24
Netto-Cashflow:
$-67.76M
1W Leistung:
+1.66%
1M Leistung:
+0.61%
6M Leistung:
-16.07%
1J Leistung:
-12.79%
1-Tages-Spanne:
$4.79
$4.99
1-Wochen-Bereich:
$4.60
$5.11
52-Wochen-Spanne:
$3.5001
$12.40
Monte Rosa Therapeutics Inc Stock (GLUE) Company Profile
Firmenname
Monte Rosa Therapeutics Inc
Sektor
Branche
Telefon
617-949-2643
Adresse
321 HARRISON AVENUE, BOSTON
Vergleichen Sie GLUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLUE
Monte Rosa Therapeutics Inc
|
4.91 | 303.86M | 0 | -130.41M | -67.76M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Monte Rosa Therapeutics Inc Stock (GLUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-19 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-02-15 | Eingeleitet | Wedbush | Outperform |
| 2023-01-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-13 | Eingeleitet | UBS | Buy |
| 2022-08-15 | Eingeleitet | Jefferies | Buy |
| 2022-04-28 | Eingeleitet | Credit Suisse | Neutral |
| 2022-02-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-10-14 | Eingeleitet | SVB Leerink | Mkt Perform |
Alle ansehen
Monte Rosa Therapeutics Inc Aktie (GLUE) Neueste Nachrichten
Chart based analysis of Monte Rosa Therapeutics Inc. trendsJuly 2025 Decliners & Fast Exit Strategy with Risk Control - Newser
Can Monte Rosa Therapeutics Inc. disrupt its industryWeekly Trade Recap & High Accuracy Swing Trade Signals - khodrobank.com
When is the best time to exit Monte Rosa Therapeutics Inc.July 2025 Recap & Verified Chart Pattern Trade Signals - Newser
Will Monte Rosa Therapeutics Inc. benefit from macro trends2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - Newser
What are the risks of holding Monte Rosa Therapeutics Inc.July 2025 Earnings & Short-Term Swing Trade Alerts - khodrobank.com
Sector ETF performance correlation with Monte Rosa Therapeutics Inc.Gold Moves & High Accuracy Trade Alerts - Newser
Can a trend reversal in Monte Rosa Therapeutics Inc. lead to recoveryQuarterly Performance Summary & Risk Controlled Stock Pick Alerts - Newser
Will Monte Rosa Therapeutics Inc. rebound enough to break even2025 Price Targets & Reliable Breakout Stock Forecasts - Newser
What is Monte Rosa Therapeutics Inc. s revenue forecast2025 Earnings Impact & Risk Adjusted Buy and Sell Alerts - khodrobank.com
How hedge fund analytics apply to Monte Rosa Therapeutics Inc. stockQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Published on: 2025-09-03 01:10:16 - khodrobank.com
Will breakout in Monte Rosa Therapeutics Inc. lead to full recoveryJuly 2025 Trends & AI Powered Trade Plan Recommendations - Newser
Will Monte Rosa Therapeutics Inc. benefit from geopolitical trendsWeekly Trend Recap & Smart Swing Trading Techniques - khodrobank.com
What are Monte Rosa Therapeutics Inc.’s recent SEC filings showingEarnings Trend Report & Consistent Profit Alerts - khodrobank.com
What MACD and RSI say about Monte Rosa Therapeutics Inc.2025 Price Action Summary & Fast Entry and Exit Trade Plans - Newser
How sentiment analysis helps forecast Monte Rosa Therapeutics Inc.Volume Spike & AI Driven Stock Reports - Newser
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Trendlines Converge — Decision Point for Monte Rosa Therapeutics Inc.Short Setup & High Accuracy Buy Signal Tips - beatles.ru
Molecular Glue Degrader Pioneer Monte Rosa Therapeutics to Present at Major Healthcare Forums - Stock Titan
Layoff Watch: What’s the outlook for Monte Rosa Therapeutics Inc.’s sector2025 Dividend Review & Free Low Drawdown Momentum Trade Ideas - khodrobank.com
Published on: 2025-09-02 00:58:19 - Newser
How does Monte Rosa Therapeutics Inc. score in quality rankingsJuly 2025 Summary & Consistent Return Strategy Ideas - khodrobank.com
What data driven models say about Monte Rosa Therapeutics Inc.’s futureJuly 2025 EndofMonth & Real-Time Market Sentiment Alerts - Newser
What moving averages say about Monte Rosa Therapeutics Inc.Earnings Overview Report & Risk Controlled Daily Trade Plans - Newser
Should I set a stop loss on Monte Rosa Therapeutics Inc.July 2025 Levels & Daily Chart Pattern Signals - khodrobank.com
Risk vs reward if holding onto Monte Rosa Therapeutics Inc.Earnings Trend Report & Weekly High Conviction Ideas - Newser
Predicting Monte Rosa Therapeutics Inc. trend using moving averagesTrade Ideas & Verified Technical Signals - Newser
Order flow analysis tools used on Monte Rosa Therapeutics Inc.Portfolio Risk Summary & Real-Time Volume Trigger Notifications - Newser
Statistical indicators supporting Monte Rosa Therapeutics Inc.’s strength2025 Price Targets & Fast Entry High Yield Stock Tips - Newser
Candlestick signals on Monte Rosa Therapeutics Inc. stock today2025 Year in Review & Low Risk High Reward Trade Ideas - Newser
Is Monte Rosa Therapeutics Inc. still worth holding after the dipMarket Trend Report & Weekly Top Gainers Trade List - Newser
What’s the recovery path for long term holders of Monte Rosa Therapeutics Inc.Stop Loss & Stepwise Swing Trade Plans - Newser
Published on: 2025-08-31 01:26:52 - Newser
Is it too late to sell Monte Rosa Therapeutics Inc.Quarterly Market Review & Weekly Top Gainers Trade List - Newser
Relative strength of Monte Rosa Therapeutics Inc. in sector analysisTrade Exit Summary & Consistent Return Investment Signals - Newser
What momentum shifts mean for Monte Rosa Therapeutics Inc.July 2025 WrapUp & AI Forecast for Swing Trade Picks - Newser
Live Chart Scan Detects Wedge Pattern in Monte Rosa Therapeutics Inc.Weekly Loss Report & Real-Time Price Movement Reports - beatles.ru
Finanzdaten der Monte Rosa Therapeutics Inc-Aktie (GLUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Monte Rosa Therapeutics Inc-Aktie (GLUE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Leo Chandra P. | Director |
Mar 24 '25 |
Buy |
5.84 |
10,000 |
58,383 |
10,000 |
| Versant Venture Capital VI, L. | 10% Owner |
Oct 28 '24 |
Sale |
9.66 |
89,990 |
869,240 |
2,007,948 |
| Versant Venture Capital VI, L. | 10% Owner |
Oct 29 '24 |
Sale |
9.16 |
67,905 |
621,801 |
1,573,453 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):